Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis

BACKGROUND: The current definition of severe eosinophilic asthma (SEA) super-responders to biologic treatment does not include patients with other eosinophil-based comorbidities. Although eosinophilic granulomatosis with polyangiitis (EGPA) is frequently associated with SEA, we lack data on a possib...

Descripción completa

Detalles Bibliográficos
Autores principales: Portacci, Andrea, Campisi, Raffaele, Buonamico, Enrico, Nolasco, Santi, Pelaia, Corrado, Crimi, Nunzio, Benfante, Alida, Triggiani, Massimo, Spadaro, Giuseppe, Caiaffa, Maria Filomena, Scioscia, Giulia, Detoraki, Aikaterini, Valenti, Giuseppe, Papia, Francesco, Tomasello, Alessandra, Scichilone, Nicola, Pelaia, Girolamo, Crimi, Claudia, Carpagnano, Giovanna Elisiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613971/
https://www.ncbi.nlm.nih.gov/pubmed/37908397
http://dx.doi.org/10.1183/23120541.00419-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613971/
https://www.ncbi.nlm.nih.gov/pubmed/37908397
http://dx.doi.org/10.1183/23120541.00419-2023

Ejemplares similares